Ron Holtz - 20 Mar 2023 Form 4 Insider Report for MAXCYTE, INC. (MXCT)

Reporting relationship: Chief Financial Officer
Issuer ticker: MXCT
Reported as of: 20 Mar 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 21 Mar 2023, 16:46:44 UTC
Prior SEC filing: 29 Mar 2022
Source filing: View source filing
Reporting owner signature: /s/ Brian F. Leaf, Attorney-in-Fact

Key filing fact

Ron Holtz filed Form 4 for MAXCYTE, INC. (MXCT) on 21 Mar 2023.

Key facts

This page summarizes Ron Holtz's Form 4 filing for MAXCYTE, INC. (MXCT).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 21 Mar 2023, 16:46.

Change

Previous filing in this sequence was filed on 29 Mar 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MXCT transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value: $0
Shares: +120,000
Change %
Price: $0.000000
Shares after: 120,000
Date: 20 Mar 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 120,000
Exercise price: $4.19
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

25% of the shares underlying this option vest on March 20, 2024 and the remaining 75% vest in 36 equal monthly installments thereafter, subject to the reporting person's continuous service with the Issuer at each vesting date.